Blog
Paving the way for a more inclusive
Industry 4.0

Paving the way for a more inclusive Industry 4.0

There is a significant gender gap that continues to exist in Science, Technology, Engineering and Mathematics (STEM) fields around the world. Even though we are seeing an increase in women pursuing these fields at a higher education level, they are still underrepresented post-graduation. With an aim to achieve full and equal access to and participation in science for women and girls, and further achieve gender equality and the empowerment of women and girls, the United Nations General Assembly declared 11 February as the International Day of Women and Girls in Science in 2015. More…

World Cancer Day
Blog
World Cancer Day: Innovations in the
fight against cancer

World Cancer Day: Innovations in the fight against cancer

Cancer is an affliction that has been known to humanity for thousands of years. According to a new study published in the British Journal of Cancer claiming 1 in 2 people will be diagnosed with the disease at some point in their lives, making the importance of research and development in this area is undeniable. During the past 250 years we have witnessed many ground-breaking discoveries in our efforts to fight cancer. Let’s take a closer look at some of these past and current developments that have helped prolong and save countless lives.

More…

AI
Blog
The possible impact of AI on life
sciences IP strategies

The possible impact of AI on life sciences in IP strategies

A stream of recent licensing deals between big pharma companies and AI-driven drug development innovators reflects an evolution that has been picking up pace in recent years. Pharmaceutical companies are integrating, more and more, artificial intelligence and other data-based technologies into their business models. This trend suggests pharma innovators are leaning increasingly heavily on AI technology owners. The increase in cash flow into the healthcare AI sector could lead to several IP strategy implications for life sciences organisations, pointed out in IAM Media’s article. More…

Blog
What does patent data reveal about
climate change mitigation technology trends?

What does patent data reveal about climate change mitigation technology trends?

Patent data is used by innovators and organisations to better understand a technology landscape, identify interesting areas for innovation and help inform on the commercial viability of an invention. With green technology a hot topic and the consequences of climate change very clear, patent data can reveal some interesting climate change mitigation technology trends, identify areas of growth, as well as areas that aren’t advancing quite so quickly. More…

Blog
What’s new in the IPC 2022.01?

What’s new in the IPC 2022.01?

The new version of the IPC 2022.01 is now live! You will be able to include the new patent classification codes that came into force on the 1st of January in your comprehensive searches in PatBase as they start being assigned. More…

charities
Blog
Charities Minesoft has supported in
2021

Throughout the year, Minesoft is committed to supporting local and national charities, helping to fund essential research and reach the most vulnerable people in our society. This year we are proud to have supported the Alzheimer’s Society, the Poppy Factory, the Vineyard Community and the Royal Overseas League. More…

Blog
Festive patents to bring some holiday cheer!

Each year, inventors are inspired by the festive period and come up with an array of novel ideas to celebrate the holidays. Many inventors will decide to protect their creations and their intellectual property by applying for a patent, which will sometimes in turn allow them to commercialise the said invention. So, let’s dive into some of the finest festive patents! More…

Blog
Pfizer signs deal allowing generics to produce COVID pill

Pfizer signs deal allowing generics to produce COVID pill

On the 16th of November, Pfizer announced a deal with international public health group Medicines Patent Pool (MPP) that will allow generic drug manufacturers to produce and supply its experimental antiviral COVID-19 pill. The licensing agreement will authorise the MPP to grant sub-licenses to qualified drug companies in 95 low and middle-income countries, giving residents access to affordable life-saving treatment.  More…